Turbo cancer is a term used to describe cases of unusually aggressive, rapidly progressing cancers that emerge or worsen following COVID-19 vaccination, particularly with mRNA vaccines (e.g., Pfizer-BioNTech, Moderna). These cancers are characterized by:
Rapid onset or progression, often in younger individuals or those previously in remission.
Resistance to conventional treatments.
A temporal association with vaccination, especially after booster doses.